FDAnews
www.fdanews.com/articles/156812-scotus-snub-of-momenta-maintains-expansive-safe-harbor-protections

SCOTUS Snub of Momenta Maintains Expansive Safe Harbor Protections

July 2, 2013
The Supreme Court’s decision June 24 not to review the Federal Circuit’s decision in Momenta v. Amphastar effectively maintains an expansive safe-harbor landscape for generic drugmakers that protects both pre- and post-approval activities that might otherwise infringe brand patents.
Washington Drug Letter